Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Buys Flow Cytometry Firm Blue Ocean Biomedical

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced late Thursday it has acquired flow cytometry firm Blue Ocean Biomedical for an undisclosed amount.

According to Beckman Coulter, the deal provides it with low complexity analyzers that integrate automated sample preparation. It added the acquisition will allow it to directly address emerging flow cytometry market trends.

Blue Ocean's instruments are based on a "sample in, result out," or SIRO, approach that Beckman said represents "a fundamental change in the routine clinical analysis sector." Its SIRO solution is the only one for clinical flow cytometry.

"This acquisition provides both immediate opportunity and long-term value," Scott Atkin, president of Beckman Coulter Life Sciences, said in a statement. "The simplification of customer workflows will be dramatic. We'll be able to offer customers an extended line of market leading technology while expanding our reach within a key segment for flow cytometry."

Blue Ocean is based in Pembroke Pines, Fla.

Beckman Coulter Life Sciences is part of Beckman Coulter, which was acquired last year by Danaher for $6.8 billion.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.